JP2022543859A5 - - Google Patents
Info
- Publication number
- JP2022543859A5 JP2022543859A5 JP2022507792A JP2022507792A JP2022543859A5 JP 2022543859 A5 JP2022543859 A5 JP 2022543859A5 JP 2022507792 A JP2022507792 A JP 2022507792A JP 2022507792 A JP2022507792 A JP 2022507792A JP 2022543859 A5 JP2022543859 A5 JP 2022543859A5
- Authority
- JP
- Japan
- Prior art keywords
- pyran
- tetrahydro
- triazole
- thio
- hydroxymethyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP2019071399 | 2019-08-09 | ||
| EPPCT/EP2019/071399 | 2019-08-09 | ||
| PCT/EP2020/072197 WO2021028323A1 (en) | 2019-08-09 | 2020-08-06 | (2-acetamidyl)thio-beta-d-galactopyranoside derivatives |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022543859A JP2022543859A (ja) | 2022-10-14 |
| JP2022543859A5 true JP2022543859A5 (enExample) | 2023-08-14 |
| JP7612663B2 JP7612663B2 (ja) | 2025-01-14 |
Family
ID=71944145
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022507792A Active JP7612663B2 (ja) | 2019-08-09 | 2020-08-06 | （２－アセタミジル）チオ－ベータ－ｄ－ガラクトピラノシド誘導体 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US12410208B2 (enExample) |
| EP (1) | EP4010348B1 (enExample) |
| JP (1) | JP7612663B2 (enExample) |
| KR (1) | KR102863667B1 (enExample) |
| CN (1) | CN114206892A (enExample) |
| CA (1) | CA3147078A1 (enExample) |
| ES (1) | ES2974680T3 (enExample) |
| TW (1) | TWI860392B (enExample) |
| WO (1) | WO2021028323A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12404295B2 (en) | 2019-08-09 | 2025-09-02 | Idorsia Pharmaceuticals Ltd | (Hetero)aryl-methyl-thio-beta-D-galactopyranoside derivatives |
| MA56883B1 (fr) | 2019-08-15 | 2025-04-30 | Idorsia Pharmaceuticals Ltd | Dérivés de 2-hydroxycycloalcane-1-carbamoyle |
| CN114585619B (zh) | 2019-08-29 | 2024-09-27 | 爱杜西亚药品有限公司 | α-D-吡喃半乳糖苷衍生物 |
| WO2022073969A1 (en) | 2020-10-06 | 2022-04-14 | Idorsia Pharmaceuticals Ltd | Spiro derivatives of alpha-d-galactopyranosides |
| US12291520B2 (en) | 2020-11-02 | 2025-05-06 | Idorsia Pharmaceuticals Ltd | Galectin-3 inhibiting 2-hydroxycycloalkane-1-carbamoyl derivatives |
| JP7844491B2 (ja) | 2021-02-09 | 2026-04-13 | イドルシア・ファーマシューティカルズ・リミテッド | ヒドロキシヘテロシクロアルカン－カルバモイル誘導体 |
| WO2022184755A1 (en) | 2021-03-03 | 2022-09-09 | Idorsia Pharmaceuticals Ltd | Triazolyl-methyl substituted alpha-d-galactopyranoside derivatives |
| WO2022189459A2 (en) * | 2021-03-10 | 2022-09-15 | Galecto Biotech Ab | Novel galactoside inhibitor of galectins |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE0100172D0 (sv) | 2001-01-22 | 2001-01-22 | Ulf Nilsson | New inhibitors against galectins |
| SE0401300D0 (sv) | 2004-05-21 | 2004-05-21 | Forskarpatent I Syd Ab | Novel Galactoside Inhibitors of Galectins |
| SE0401301D0 (sv) * | 2004-05-21 | 2004-05-21 | Forskarpatent I Syd Ab | Novel 3-triazolyl-galactoside inhibitors of galectins |
| EP2620443A1 (en) | 2012-01-25 | 2013-07-31 | Galecto Biotech AB | Novel galactoside inhibitors of galectins |
| KR102231732B1 (ko) | 2012-10-10 | 2021-03-23 | 갈렉틴 테라퓨틱스, 인크. | 당뇨병성 신장병증 및 관련 질환의 치료를 위한 갈락토스 갈래의 탄수화물 화합물 |
| IN2015DN02573A (enExample) | 2012-10-31 | 2015-09-11 | Galecto Biotech Ab | |
| EP2919802A4 (en) | 2012-11-15 | 2016-09-14 | Univ Tufts | METHOD, COMPOSITIONS AND KITS FOR TREATING, MODULATING OR PREVENTING ANGIOGENESIS OR FIBROSIS IN A PATIENT USING A GALECTINE PROTEIN HEMMER |
| CA2970062C (en) | 2015-01-30 | 2023-02-28 | Galecto Biotech Ab | Alpha-d-galactoside inhibitors of galectins |
| ES2734713T3 (es) | 2015-07-06 | 2019-12-11 | Gilead Sciences Inc | Moduladores Cot y métodos de utilización de los mismos |
| PL3359541T3 (pl) * | 2015-10-09 | 2021-01-11 | AbbVie Overseas S.à r.l. | N-SULFONYLOWANE PIRAZOLO[3,4-b]PIRYDYNO-6-KARBOKSAMIDY I SPOSÓB ZASTOSOWANIA |
| CN109563119A (zh) * | 2016-07-12 | 2019-04-02 | 格莱克特生物技术公司 | 半乳糖凝集素的α-D-半乳糖苷抑制剂 |
| KR102626669B1 (ko) | 2017-05-12 | 2024-01-17 | 갈랙틴 사이언시즈, 엘엘씨 | 질환의 예방 및 치료를 위한 화합물 및 이의 용도 |
| CA3062649A1 (en) | 2017-05-12 | 2018-11-15 | Galectin Sciences, Llc | Compounds for the treatment of systemic insulin resistance disorders and the use thereof |
| US11267811B2 (en) * | 2017-09-27 | 2022-03-08 | Bristol-Myers Squibb Company | Small molecule inhibitors of galectin-3 |
| WO2019075045A1 (en) | 2017-10-11 | 2019-04-18 | Bristol-Myers Squibb Company | INHIBITORS WITH SMALL MOLECULES OF GALECTIN-3 |
| JP2021501180A (ja) * | 2017-10-31 | 2021-01-14 | ガレクティン・サイエンシーズ・リミテッド・ライアビリティ・カンパニーＧａｌｅｃｔｉｎ Ｓｃｉｅｎｃｅｓ， ＬＬＣ | 全身インスリン抵抗性障害の治療のためのセレノガラクトシド化合物およびその使用 |
| CN113286632A (zh) | 2018-10-15 | 2021-08-20 | 格莱克特生物技术公司 | 半乳糖凝集素的半乳糖苷抑制剂前药 |
| CN113366007A (zh) | 2018-10-15 | 2021-09-07 | 格莱克特生物技术公司 | 半乳糖凝集素的半乳糖苷抑制剂 |
| US11447517B2 (en) | 2018-11-21 | 2022-09-20 | Galecto Biotech Ab | Galactoside inhibitor of galectins |
| US12269819B2 (en) | 2019-04-10 | 2025-04-08 | Bristol-Myers Squibb Company | Small molecule inhibitors of Galectin-3 |
| JP7674276B2 (ja) | 2019-07-03 | 2025-05-09 | ガレクト バイオテック エービー | ガレクチンの新規なガラクトシド阻害剤 |
| CA3143078A1 (en) | 2019-07-05 | 2021-01-14 | Galecto Biotech Ab | Novel galactoside inhibitor of galectins |
| US12404295B2 (en) | 2019-08-09 | 2025-09-02 | Idorsia Pharmaceuticals Ltd | (Hetero)aryl-methyl-thio-beta-D-galactopyranoside derivatives |
| MA56883B1 (fr) | 2019-08-15 | 2025-04-30 | Idorsia Pharmaceuticals Ltd | Dérivés de 2-hydroxycycloalcane-1-carbamoyle |
| CN114585619B (zh) | 2019-08-29 | 2024-09-27 | 爱杜西亚药品有限公司 | α-D-吡喃半乳糖苷衍生物 |
| WO2022073969A1 (en) | 2020-10-06 | 2022-04-14 | Idorsia Pharmaceuticals Ltd | Spiro derivatives of alpha-d-galactopyranosides |
| US12291520B2 (en) | 2020-11-02 | 2025-05-06 | Idorsia Pharmaceuticals Ltd | Galectin-3 inhibiting 2-hydroxycycloalkane-1-carbamoyl derivatives |
| JP7844491B2 (ja) | 2021-02-09 | 2026-04-13 | イドルシア・ファーマシューティカルズ・リミテッド | ヒドロキシヘテロシクロアルカン－カルバモイル誘導体 |
| WO2022184755A1 (en) | 2021-03-03 | 2022-09-09 | Idorsia Pharmaceuticals Ltd | Triazolyl-methyl substituted alpha-d-galactopyranoside derivatives |
-
2020
- 2020-08-06 KR KR1020227007694A patent/KR102863667B1/ko active Active
- 2020-08-06 CA CA3147078A patent/CA3147078A1/en active Pending
- 2020-08-06 US US17/633,941 patent/US12410208B2/en active Active
- 2020-08-06 ES ES20750677T patent/ES2974680T3/es active Active
- 2020-08-06 WO PCT/EP2020/072197 patent/WO2021028323A1/en not_active Ceased
- 2020-08-06 JP JP2022507792A patent/JP7612663B2/ja active Active
- 2020-08-06 EP EP20750677.5A patent/EP4010348B1/en active Active
- 2020-08-06 CN CN202080056498.7A patent/CN114206892A/zh active Pending
- 2020-08-07 TW TW109126970A patent/TWI860392B/zh active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022543666A5 (enExample) | ||
| JP2023514872A5 (enExample) | ||
| CN106029064B (zh) | 治疗化合物和组合物 | |
| JP6014148B2 (ja) | ヤヌスキナーゼ阻害剤としてのシクロアルキルニトリルピラゾールカルボキサミド | |
| JP2022544248A5 (enExample) | ||
| JP6013734B2 (ja) | キノロン化合物の製造方法 | |
| JP2024506182A5 (enExample) | ||
| JP2022552655A5 (enExample) | ||
| EA032609B1 (ru) | Соединения аминопиримидинила в качестве ингибиторов jak | |
| JP2024509421A5 (enExample) | ||
| JP2005533827A5 (enExample) | ||
| RU2001126337A (ru) | Соединения, пригодные в качестве противовоспалительных агентов | |
| CN105008367A (zh) | 作为钾离子通道抑制剂的吡咯并三嗪类化合物 | |
| JP7604457B2 (ja) | ２－ヒドロキシシクロアルカン－１－カルバモイル誘導体 | |
| RU2010110640A (ru) | Соединения и композиции 5-(4-(галогеналкокси)фенил)пиримидин-2-амина в качестве ингибиторов киназ | |
| TW200528440A (en) | 2-cyanopyrrolidinecarboxamide compound | |
| CN111094255A (zh) | 具有环状结构的化合物 | |
| JP2018522047A (ja) | Ｒｏｒガンマモジュレータとしての新規化合物 | |
| US10464896B2 (en) | Efflux-pump inhibitors and therapeutic uses thereof | |
| JP2022546029A5 (enExample) | ||
| CN110191709A (zh) | 可用作吲哚胺2,3-双加氧酶和/或色氨酸双加氧酶抑制剂的化合物 | |
| CN105636646B (zh) | 氮杂吲哚化合物、其合成及其使用方法 | |
| EA018995B1 (ru) | Производные карбаматов алкилтиазолов, их получение и их применение в терапии | |
| CA2545092A1 (en) | Quinolonecarboxylic acid compounds having 5-ht4 receptor agonistic activity | |
| JP2023547241A5 (enExample) |